1. Home
  2. |Insights
  3. |ACI’s 28th Annual Drug & Medical Device Litigation Conference

ACI’s 28th Annual Drug & Medical Device Litigation Conference

Event | 12.05.23, 2:00 PM EST

Address

NY Marriott Marquis
1535 Broadway, New York, NY 10036

On December 5, Andrew Kaplan will speak at ACI’s 28th Annual Drug & Medical Device Litigation Conference on the panel, "Key Takeaways from this Year’s Top MDLs: Impactful Rulings and Hot Opinions from the Tylenol, Zantac and Exactech MDLs.” This program will analyze the nuances of these three MDLs and provide insights on how developments in recent OTC MDLs may impact the future of prescription pharmaceuticals.

For more information, please visit these areas: Mass Tort, Product, and Consumer Litigation

Insights

Event | 02.20.25

Has the Buss Stopped? Recoupment Today

Has the Buss Stopped? Recoupment Today: In 1997, the California Supreme Court decided Buss v. Superior Court. In Buss, the court concluded that a liability insurer that defended a mixed action could seek reimbursement from the insured for the defense costs associated with the claims that were not even potentially covered. Since then, numerous courts have held that insurers are entitled to recoup their defense costs associated with uncovered claims or causes of action. On the other hand, a significant number of courts have rejected insurers’ right to recoupment, at least in the absence of a policy provision granting the insurer that right. Some commentators have even suggested that the current judicial trend might be away from permitting insurers to recoup their defense costs. Is that correct? Has the Buss stopped? This panel of coverage experts will analyze insurers’ claimed right to recoupment today, and offer their perspectives on what the law on recoupment should perhaps be and might be in the future.